Tag: Alzheimer’s Drug Development

Eli Lilly Doubles Down on Global Pharma Dominance as Roche Bets Big on Alzheimer’s Breakthroughs: What Investors Need to Know in 2026

Big Pharma’s New Battle Isn’t About Size—It’s About Owning the Future of Medicine The global pharmaceutical industry is entering a new era where success is no longer measured only by blockbuster drugs but by innovation, strategic acquisitions, artificial intelligence, precision diagnostics, and next-generation therapies. This week, two of the world’s largest pharmaceutical companies made headlines...